The Eaton Vance Worldwide Health Sciences Fund Class A (ETHSX) is a mutual fund that focuses on investing in companies within the global health sciences industry. This includes pharmaceutical, biotechnology, medical device, and healthcare services companies. The fund aims to provide long-term capital appreciation by investing in companies with strong growth potential and innovative products or services. With a diverse portfolio of international investments, the fund offers investors exposure to the rapidly growing and ever-evolving healthcare sector.

ETHSX Mutual Fund Chart & Stats

Previous Close$13.59

Sub-CategorySector-Specific

Total Liabilities41.90M

Last Dividend Ex-Date

Dec 07, 2023

Expense Ratio1.14%

Holding Count42

Brandeaton vance growth trust

Dividend Yield

0.07 (0.49%)

CategoryEquity

Total Assets1.07B

Shares OutstandingN/A

52-Week Range$11.59 - $14.93

ETHSX Mutual Fund News

PremiumBlurbs

Johnson & Johnson’s Strategic Settlement Plan for Ovarian Cancer Talc Claims: Financial Implications and Outlook

10h ago

JNJ

PremiumBlurbs

Hold Rating on Johnson & Johnson Amid Ongoing Talc Litigation Uncertainties and Settlement Efforts

10h ago

JNJ

PremiumCompany Announcements

AstraZeneca’s Calquence Sets New Standard in Lymphoma Care

13h ago

PremiumBlurbs

Analysts Offer Insights on Healthcare Companies: Tandem Diabetes Care (TNDM) and Eli Lilly & Co (LLY)

13h ago

LLY

TNDM

ETHSX Mutual Fund Smart Score

Neutral

Analyst Consensus

Moderate Buy

Average Price Target:
$15.50 (― Downside)

Learn more about TipRanks Smart Score

For Mutual Funds, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the Mutual Fund's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual Mutual Fund ticker.